scholarly article | Q13442814 |
P50 | author | Lars Timmermann | Q21043333 |
Gereon Rudolf Fink | Q1511131 | ||
David Eidelberg | Q5233311 | ||
Carsten Eggers | Q108428565 | ||
Florian Holtbernd | Q66724680 | ||
L W Kracht | Q67217650 | ||
P2093 | author name string | Chris C Tang | |
Yilong Ma | |||
Frank Schwartz | |||
Shichun Peng | |||
P2860 | cites work | Striatal 18F-dopa uptake: absence of an aging effect | Q72900520 |
??? | Q64786077 | ||
Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder | Q27303962 | ||
Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 | ||
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
Identification of disease-related spatial covariance patterns using neuroimaging data | Q30655192 | ||
Metabolic brain networks in neurodegenerative disorders: a functional imaging approach | Q33504970 | ||
Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues | Q33726349 | ||
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease | Q33835425 | ||
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes | Q34160461 | ||
Functional brain networks in movement disorders: recent advances | Q34308197 | ||
Changes in network activity with the progression of Parkinson's disease | Q35679748 | ||
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. | Q35683286 | ||
Metabolic brain networks associated with cognitive function in Parkinson's disease | Q35684482 | ||
Anterior cingulate dopamine turnover and behavior change in Parkinson's disease | Q35748883 | ||
Metabolic brain networks in translational neurology: concepts and applications | Q36041821 | ||
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis | Q36198606 | ||
Parkinson's disease cognitive network correlates with caudate dopamine | Q36901626 | ||
Abnormal metabolic network activity in REM sleep behavior disorder | Q37658353 | ||
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo | Q42467775 | ||
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease | Q43281611 | ||
Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study | Q44125048 | ||
Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. | Q44170628 | ||
Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism | Q44819125 | ||
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. | Q44946964 | ||
Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. | Q46011395 | ||
High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease | Q46331651 | ||
Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. | Q46549687 | ||
Metabolic correlates of subthalamic nucleus activity in Parkinson's disease | Q46653986 | ||
Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease | Q46750528 | ||
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways | Q46848027 | ||
Impaired somatosensory discrimination of shape in Parkinson's disease: association with caudate nucleus dopaminergic function | Q48146679 | ||
Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing | Q48552859 | ||
[¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease | Q48868532 | ||
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. | Q48879551 | ||
Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study. | Q51160375 | ||
Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. | Q51894202 | ||
Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease | Q57988220 | ||
Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry | Q72144620 | ||
P433 | issue | 9 | |
P921 | main subject | Parkinson's disease | Q11085 |
dopamine | Q170304 | ||
metabolic network | Q2263094 | ||
P1104 | number of pages | 11 | |
P304 | page(s) | 3575-3585 | |
P577 | publication date | 2015-06-03 | |
P1433 | published in | Human Brain Mapping | Q5936947 |
P1476 | title | Dopaminergic correlates of metabolic network activity in Parkinson's disease | |
P478 | volume | 36 |
Q52099611 | Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample. |
Q64967643 | Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography. |
Q64780329 | Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder |
Q91670190 | Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies |
Q39318829 | Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases |
Q50629638 | Dynamic brain glucose metabolism identifies anti-correlated cortical-cerebellar networks at rest. |
Q38666938 | FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder |
Q64806177 | FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis |
Q37277039 | Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia |
Q42488643 | Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT. |
Q50091410 | Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia |
Q47116959 | Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia |
Q48674580 | Metabolic connectomics targeting brain pathology in dementia with Lewy bodies |
Q31158920 | Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. |
Q41492379 | Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns |
Q47632627 | Network Structure and Function in Parkinson's Disease. |
Q57178629 | Network imaging biomarkers: insights and clinical applications in Parkinson's disease |
Q52317290 | New Imaging Markers for Movement Disorders. |
Q57456370 | PET Imaging in Movement Disorders |
Q64950011 | Preserved caudate function in young-onset patients with Parkinson's disease: a dual-tracer PET imaging study. |
Search more.